Pfizer-BioNTech COVID vaccine appears more than 90% effective in kids 5 to 11
Pfizer and its partner BioNTech say their data supports authorization of their COVID-19 vaccine in kids 5 to 11. The Food and Drug Administration released the companies' briefing d…